TCL Archive DCT Board Sends Message On Cutting Grants to Extend Paylines, Then Tries To Take It Back March 2, 1984
TCL Archive Five-Year Course of Tamoxifen Remains Standard Treatment In HR+ Breast Cancer July 26, 2002
TCL Archive “Miracle-Gro for Cancer?” ODAC Members Vent At Amgen And J&J Over Claims, Advertising. May 18, 2007
TCL Archive MSK Investigators Report Sialic Acid Test 95% Accurate; Negative Immunotherapy Results Told June 13, 1980